Testimony
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with a January 11, 2012 meeting of the Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee to consider the premarket approval of the LINX Reflux Management System for the treatment of gastroesophageal reflux disease (GERD): On behalf […]
News Article
MOUNT PLEASANT, S.C., Dec. 1, 2025 /PRNewswire/ — This December for Constipation Awareness Month, IFFGD is shedding a light on common causes, prevention, and treatments. As well as promoting healthy conversations and lifestyle habits to support bowel movements. Constipation affects millions, approximately 1 out of every 6-7 people worldwide and annually leading to more than 1.5 million […]
Testimony
IFFGD President, Ceciel Rooker, submitted the following written statement to the House and Senate Committee on Appropriations, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies regarding Fiscal Year (FY) 2020 appropriations for medical research and public health programs. April 9, 2019 STATEMENT OF CECIEL T. ROOKER PRESIDENT INTERNATIONAL FOUNDATION FOR […]
An_Introduction_to_Supplements_for_Gastrointestinal_Disorders.pdf
Making_mental_health_part_of_your_healthcare_team.pdf
202_Think_It_Through_Managing_The_Benefits_And_Risks_Of_Medications.pdf
Disorder
What is Systemic Mastocytosis? A Brief Overview Systemic Mastocytosis (SM) is a rare disorder where the body produces too many mast cells, a type of immune cell that normally helps protect against infections and allergens. When these mast cells accumulate abnormally in organs like the skin, gastrointestinal (GI) tract, bone marrow, and liver, they can […]